These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32856901)

  • 1. Expanded DNA and RNA Trinucleotide Repeats in Myotonic Dystrophy Type 1 Select Their Own Multitarget, Sequence-Selective Inhibitors.
    Hagler LD; Luu LM; Tonelli M; Lee J; Hayes SM; Bonson SE; Vergara JI; Butcher SE; Zimmerman SC
    Biochemistry; 2020 Sep; 59(37):3463-3472. PubMed ID: 32856901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationally designed small molecules that target both the DNA and RNA causing myotonic dystrophy type 1.
    Nguyen L; Luu LM; Peng S; Serrano JF; Chan HY; Zimmerman SC
    J Am Chem Soc; 2015 Nov; 137(44):14180-9. PubMed ID: 26473464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A CTG repeat-selective chemical screen identifies microtubule inhibitors as selective modulators of toxic CUG RNA levels.
    Reddy K; Jenquin JR; McConnell OL; Cleary JD; Richardson JI; Pinto BS; Haerle MC; Delgado E; Planco L; Nakamori M; Wang ET; Berglund JA
    Proc Natl Acad Sci U S A; 2019 Oct; 116(42):20991-21000. PubMed ID: 31570586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy.
    Timchenko LT; Timchenko NA; Caskey CT; Roberts R
    Hum Mol Genet; 1996 Jan; 5(1):115-21. PubMed ID: 8789448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Selective Alkylating Agent for CTG Repeats in Myotonic Dystrophy Type 1.
    Lee J; Li K; Zimmerman SC
    ACS Chem Biol; 2022 May; 17(5):1103-1110. PubMed ID: 35483041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico discovery of substituted pyrido[2,3-d]pyrimidines and pentamidine-like compounds with biological activity in myotonic dystrophy models.
    González ÀL; Konieczny P; Llamusi B; Delgado-Pinar E; Borrell JI; Teixidó J; García-España E; Pérez-Alonso M; Estrada-Tejedor R; Artero R
    PLoS One; 2017; 12(6):e0178931. PubMed ID: 28582438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precise small-molecule cleavage of an r(CUG) repeat expansion in a myotonic dystrophy mouse model.
    Angelbello AJ; Rzuczek SG; Mckee KK; Chen JL; Olafson H; Cameron MD; Moss WN; Wang ET; Disney MD
    Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7799-7804. PubMed ID: 30926669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Small Molecule that Binds an RNA Repeat Expansion Stimulates Its Decay via the Exosome Complex.
    Angelbello AJ; Benhamou RI; Rzuczek SG; Choudhary S; Tang Z; Chen JL; Roy M; Wang KW; Yildirim I; Jun AS; Thornton CA; Disney MD
    Cell Chem Biol; 2021 Jan; 28(1):34-45.e6. PubMed ID: 33157036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Potent Inhibitor of Protein Sequestration by Expanded Triplet (CUG) Repeats that Shows Phenotypic Improvements in a Drosophila Model of Myotonic Dystrophy.
    Luu LM; Nguyen L; Peng S; Lee J; Lee HY; Wong CH; Hergenrother PJ; Chan HY; Zimmerman SC
    ChemMedChem; 2016 Jul; 11(13):1428-35. PubMed ID: 27245480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Plant-derived Alkaloids with Therapeutic Potential for Myotonic Dystrophy Type I.
    Herrendorff R; Faleschini MT; Stiefvater A; Erne B; Wiktorowicz T; Kern F; Hamburger M; Potterat O; Kinter J; Sinnreich M
    J Biol Chem; 2016 Aug; 291(33):17165-77. PubMed ID: 27298317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac elav-type RNA-binding protein (ETR-3) binds to RNA CUG repeats expanded in myotonic dystrophy.
    Lu X; Timchenko NA; Timchenko LT
    Hum Mol Genet; 1999 Jan; 8(1):53-60. PubMed ID: 9887331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precise small-molecule recognition of a toxic CUG RNA repeat expansion.
    Rzuczek SG; Colgan LA; Nakai Y; Cameron MD; Furling D; Yasuda R; Disney MD
    Nat Chem Biol; 2017 Feb; 13(2):188-193. PubMed ID: 27941760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenic stress modulates the dynamics of CTG repeat instability associated with myotonic dystrophy type 1.
    Piñeiro E; Fernàndez-López L; Gamez J; Marcos R; Surrallés J; Velázquez A
    Nucleic Acids Res; 2003 Dec; 31(23):6733-40. PubMed ID: 14627806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Versatile Target-Guided Screen for Discovering Bidirectional Transcription Inhibitors of a Trinucleotide Repeat Disease.
    Hagler LD; Krueger SB; Luu LM; Lanzendorf AN; Mitchell NL; Vergara JI; Curet LD; Zimmerman SC
    ACS Med Chem Lett; 2021 Jun; 12(6):935-940. PubMed ID: 34141072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myotonic dystrophy associated expanded CUG repeat muscleblind positive ribonuclear foci are not toxic to Drosophila.
    Houseley JM; Wang Z; Brock GJ; Soloway J; Artero R; Perez-Alonso M; O'Dell KM; Monckton DG
    Hum Mol Genet; 2005 Mar; 14(6):873-83. PubMed ID: 15703191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actinomycin D Specifically Reduces Expanded CUG Repeat RNA in Myotonic Dystrophy Models.
    Siboni RB; Nakamori M; Wagner SD; Struck AJ; Coonrod LA; Harriott SA; Cass DM; Tanner MK; Berglund JA
    Cell Rep; 2015 Dec; 13(11):2386-2394. PubMed ID: 26686629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic delivery of a Peptide-linked morpholino oligonucleotide neutralizes mutant RNA toxicity in a mouse model of myotonic dystrophy.
    Leger AJ; Mosquea LM; Clayton NP; Wu IH; Weeden T; Nelson CA; Phillips L; Roberts E; Piepenhagen PA; Cheng SH; Wentworth BM
    Nucleic Acid Ther; 2013 Apr; 23(2):109-17. PubMed ID: 23308382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective and Reversible Ligand Assembly on the DNA and RNA Repeat Sequences in Myotonic Dystrophy.
    Krueger SB; Lanzendorf AN; Jeon HH; Zimmerman SC
    Chembiochem; 2022 Sep; 23(17):e202200260. PubMed ID: 35790065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of pharmacophore models for small molecules targeting RNA: Application to the RNA repeat expansion in myotonic dystrophy type 1.
    Angelbello AJ; González ÀL; Rzuczek SG; Disney MD
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5792-5796. PubMed ID: 27839685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms.
    Jenquin JR; Coonrod LA; Silverglate QA; Pellitier NA; Hale MA; Xia G; Nakamori M; Berglund JA
    ACS Chem Biol; 2018 Sep; 13(9):2708-2718. PubMed ID: 30118588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.